See More Hear More Watch More Hear More Get on iTunes
WSJ Daily Minute WSJMinute

Vertex drug sparks legal battle

Vertex Pharmaceuticals’ $300,000-a-year cystic-fibrosis drug has sparked a legal battle in Arkansas, illustrating the dilemma faced by cash-strapped government insurance programs. http://online.wsj.com/articles/costly-drug-vertex-is-denied-and-medicaid-patients-sue-1405564205?mod=WSJ_hp_RightTopStories

UP NEXT

More from